John James O'Connor - Dec 10, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 10, 2025
Transactions value $
$0
Form type
4
Date filed
12/11/2025, 06:08 PM
Previous filing
Dec 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Connor John James Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 2025-12-11 0001382475

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Award $0 +533 +0.86% $0.00 62.3K Dec 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Award $0 +3.43K $0.00 3.43K Dec 10, 2025 Common Stock 3.43K $83.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.
F2 This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.